Effect of Puran Guda and Katu tail in management of Bronchial Asthama

Phase 3

• Conditions: Health Condition 1: J459- Other and unspecified asthma

• Registration Number: CTRI/2019/03/017937
• Lead Sponsor: Chaudhary Braham Prakash Ayurved Charak Sansthan Khera Dabar New Delhi

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1.Patients having the clinical feature of Tamaka Shwasa described in Ayurvedic classics or Bronchial Asthma modern literature-

1.Shwasa teevrvega(Breathlessness).

2.Kasa (paroxysmal cough).

3.Ghurghurakam (wheezing).

4.Nidranasha (sleeplessness).

5.Shyana shwaspeeditam(breathlessness during sleep).

6.Parsve-avagrihyate(chest tightness).

7.Lalate swedate(sweating on forehead).

8.Aasino labhtesaukhyam(dyspnoea relived in sitting position.

2.Patients exhibiting either symptoms of Bronchial Asthma as following GINA criteria for diagnosis of Asthma.

3. Age â?? 18-60 years

4. Sex â?? both

5.Patients receiving standard Ayurvedic preparation for Bronchial Asthma.

6. patients with firm home address and contact no which is readily accessible during course of trial.

Exclusion Criteria

1.Seriously ill and moribund patients.

2.Hypersensitivity to any of the herbal dravyas.

3.Concomitant ayurvedic or any other treatment for any illness.

4.Abnormal renal or hepatic functions.

5.Patients planning to conceive in near future (during course of trial).

6.Pregnant and lactating mothers.

7.Any other pre -existing illness that will require surgery during course of trial.

8.Any major psychiatric illness.

9.Patients with any other concomitant lung disorder.

10.Patients having weak digestive capacity or suffering from indigestion.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Reduction in rate of severe asthma. <br/ ><br> Day and night time symptoms of Asthma <br/ ><br> <br/ ><br>.Day and night time symptoms of Asthma <br/ ><br>Timepoint: day 0 day 7 day 14 day 21 day 28 day 35 day 42 <br/ ><br>

Secondary Outcome Measures

Name	Time	Method
. Reduced eosinophil in blood <br/ ><br> Reduced serum Ig E <br/ ><br>. Reduced total eosinophil count <br/ ><br>Timepoint: day 0 day 7 day 14 day 21 day 28 day 35 day 42